Management focuses on rapid reperfusion with intravenously administered tissue-plasminogen activator (tPA), also known as thrombolytic therapy, and mechanical thrombectomy, which both are well accepted to restore brain function for acute cerebral ischemia during a limited treatment window after stroke 4, 5. The gene discussed is PLAT; the disease is Stroke.